SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-026164
Filing Date
2018-05-08
Accepted
2018-05-08 16:39:36
Documents
76
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv491727_10q.htm 10-Q 325202
2 EXHIBIT 31.1 tv491727_ex31-1.htm EX-31.1 8639
3 EXHIBIT 31.2 tv491727_ex31-2.htm EX-31.2 8798
4 EXHIBIT 32.1 tv491727_ex32-1.htm EX-32.1 4127
5 EXHIBIT 32.2 tv491727_ex32-2.htm EX-32.2 4355
  Complete submission text file 0001144204-18-026164.txt   4478765

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xtnt-20180331.xml EX-101.INS 964816
7 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20180331.xsd EX-101.SCH 48994
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20180331_cal.xml EX-101.CAL 57591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20180331_def.xml EX-101.DEF 348643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20180331_lab.xml EX-101.LAB 375411
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20180331_pre.xml EX-101.PRE 383298
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 18815264
SIC: 2836 Biological Products, (No Diagnostic Substances)